Novel biomarkers detected by proteomics predict death and cardiovascular events in hemodialysis patients

Background. End-stage kidney disease increases mortality and the risk of cardiovascular (CV) disease. It is crucial to explore novel biomarkers to predict CV disease in the complex setting of patie ...